This was pretty much free-market business No, it wasn't free-market at all. Much of Shkreli's strategy relied on the barrier to entry created by FDA regulation

This was pretty much free-market business No, it wasn't free-market at all. Much of Shkreli's strategy relied on the barrier to entry created by FDA regulations. He priced the drug just low enough that it wouldn't be worthwhile for another manufacturer to get approved. Nothing free market here. It's rent seeking, pure and simple.